Welcome to our patient information site where you will learn more about benign prostatic hyperplasia (BPH),
find out how severe your symptoms are and learn about treatment options.
NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is to improve the standard of care for patients with Benign Prostatic Hyperplasia (BPH), a broadly underserved market. Our first product is the UroLift® System, a minimally invasive device designed to treat lower urinary tract symptoms (LUTS) due to BPH.
NeoTract, Inc. was founded in 2004 through the ExploraMed Development, LLC medical device incubator funded by New Enterprise Associates. The Company's headquarters are in Pleasanton, California, USA